HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.

Abstract
Hypoxia is a general characteristic of most solid malignancies and intimately related to neoplastic diseases and cancer progression. Homeostatic response to hypoxia is primarily mediated by hypoxia inducible factor (HIF)-1α that elicits transcriptional activity through recruitment of the CREB binding protein (CBP)/p300 coactivator. Targeted blockade of HIF-1α binding to CBP/p300 would thus constitute a novel approach for cancer treatment by suppressing tumor angiogenesis and metastasis. Here, we identified inhibitors against the interaction between HIF-1α and p300 by a fluorescence polarization-based assay employing a fluorescently-labeled peptide containing the C-terminal activation domain of HIF-1α. Two small molecule inhibitors, menadione (MD) and ethacrynic acid (EA), were found to decrease expression of luciferase under the control of hypoxia-responsive elements in hypoxic cells as well as to efficiently block the interaction between the full-length HIF-1α and p300. While these compounds did not alter the expression level of HIF-1α, they down-regulated expression of a HIF-1α target vascular endothelial growth factor (VEGF) gene. Considering hypoxia-induced VEGF expression leading to highly aggressive tumor growth, MD and EA may provide new scaffolds for development of tumor therapeutic reagents as well as tools for a better understanding of HIF-1α-mediated hypoxic regulation.
AuthorsYu-Ran Na, Ki-Cheol Han, Hyunsung Park, Eun Gyeong Yang
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 434 Issue 4 Pg. 879-84 (May 17 2013) ISSN: 1090-2104 [Electronic] United States
PMID23618863 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Vascular Endothelial Growth Factor A
  • Vitamin K 3
  • Luciferases
  • E1A-Associated p300 Protein
  • EP300 protein, human
  • Ethacrynic Acid
Topics
  • Binding Sites (genetics)
  • Cell Hypoxia
  • Cell Survival (drug effects)
  • Dose-Response Relationship, Drug
  • E1A-Associated p300 Protein (genetics, metabolism)
  • Ethacrynic Acid (chemistry, pharmacology)
  • Gene Expression (drug effects)
  • HeLa Cells
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (genetics, metabolism)
  • Immunoblotting
  • Luciferases (genetics, metabolism)
  • Molecular Structure
  • Protein Binding (drug effects)
  • Protein Interaction Mapping (methods)
  • Response Elements (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction (drug effects)
  • Vascular Endothelial Growth Factor A (genetics)
  • Vitamin K 3 (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: